The stock of AC Immune Ltd (NASDAQ:ACIU) is a huge mover today! The stock increased 9.37% or $1.08 on November 25, hitting $12.61. About 269,075 shares traded hands or 75.28% up from the average. AC Immune Ltd (NASDAQ:ACIU) has risen 6.00% since October 26, 2016 and is uptrending. It has outperformed by 0.59% the S&P500.
The move comes after 5 months positive chart setup for the $584.37M company. It was reported on Nov, 25 by Barchart.com. We have $13.49 PT which if reached, will make NASDAQ:ACIU worth $40.91 million more.
According to Zacks Investment Research, “AC Immune SA is a biopharmaceutical company. It develops, discover and design novel, proprietary medicines for prevention, diagnosis and treatment of neurodegenerative diseases. The Company’s pipeline includes Crenezumab, ACI-24, Anti-Tau antibody, Morphomer Tau, Tau-PET imaging agent, Morphomer Abeta and Morphomer alpha-syn which are in clinical trial. AC Immune SA is based in Lausanne, Switzerland.”
More news for AC Immune Ltd (NASDAQ:ACIU) were recently published by: Globenewswire.com, which released: “AC IMMUNE APPOINTS EXPERIENCED LIFE SCIENCE PROFESSIONAL AS NEW CHIEF …” on November 23, 2016. Businesswire.com‘s article titled: “Down Syndrome Pipeline Review, H1 2016 Featuring AC Immune, Aelis Farma S.A.S …” and published on March 23, 2016 is yet another important article.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.